BioNexus Gene Lab Corp

NEW
NAS:BGLC (Malaysia)   Ordinary Shares
$ 1.7 +0.020 (+1.19%) 11:40 AM EST
At Loss
P/B:
0.51
Market Cap:
$ 4.11M
Enterprise V:
$ 361.00K
Volume:
3.09K
Avg Vol (2M):
151.46K
Trade In:
Volume:
3.09K
At Loss
Avg Vol (2M):
151.46K

BioNexus Gene Lab Corp (BGLC) Dividend

BioNexus Gene Lab Corp (BGLC) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -18.6%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: BGLC Dividend

Does BioNexus Gene Lab Corp (BGLC) pay a dividend?

BioNexus Gene Lab Corp (BGLC) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't BioNexus Gene Lab Corp pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. BioNexus Gene Lab Corp has returned capital to shareholders via buybacks at a rate of -18.6% over the past 3 years.

What are dividend-paying alternatives to BioNexus Gene Lab Corp?

For dividend-paying alternatives in BioNexus Gene Lab Corp's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.